Cannvas Retains Michael Bluestein as External Counsel
TORONTO , July 4, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: "MTEC"), a leading business technology company within the cannabis space, is pleased to announce that Michael Bluestein of CC Corporate Counsel Professional Corporation ("Corporate Counsel") has been engaged to support and enhance the Company's strategic partnership efforts, corporate governance directives and general legal requirements.
"Michael will provide strategic counsel to our organization and will be a key resource in our efforts to build Cannvas into a leading technology company in the cannabis health services sector," said Shawn Moniz , chief executive officer of Cannvas. "As a founding partner at Corporate Counsel, he provides senior counsel on a diverse range of issues to private and public corporations and has a deep understanding of the legal landscape in the Canadian technology industry. We will also benefit from his extensive expertise in corporate governance and compliance, having recently completed our listing on the Canadian Stock Exchange."
Michael is a senior corporate and securities lawyer at Corporate Counsel with more than 10 years of experience working with public companies. His strengths include driving for results, strategic thinking and superior client service. Michael's goal is to provide clients with practical solutions to problems while being cognizant of turn-around time and budget.
Michael has a strong background in corporate finance and has advised a wide range of clients on private equity, venture capital, M&A and other types of transactions. He has advised numerous public companies and assisted with the creation of two new stock exchanges from the ground up. Michael also has extensive experience in the technology industry from his previous counsel roles as well as from founding a tech start-up. Michael's goal is to provide Bay Street expertise and service without the Bay Street price. He feels that clients should pay for great advice and not large overheads.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
View original content with multimedia: http://www.newswire.ca/en/releases/archive/July2018/04/c5554.html